Recipharm completes Korean serialisation project for Abbott

By Zachary Brennan contact

- Last updated on GMT

Related tags: People's republic of china, South korea

Recipharm completes Korean serialisation project for Abbott
The Korean project, which began in April 2014, required the Sweden-based CDMO (contract development and manufacturing organization) Recipharm to produce a data matrix code, including serial number, to comply with the regulations that are expected to be similar to what’s foreseen in serialisation in the EU.  

Recipharm applied its solution, designed to achieve full compliance with country-specific regulations, to a blister packaging line. Validation batches are now manufactured released and planned to be shipped to Korea beginning in mid-March. Though similar to the EU, the company said the Korean serialisation differed markedly from what’s expected in China.
From the outset, integration formed a key tenet in the collaboration between the two companies, with the establishment of joint company strategic teams and the sharing of critical information, Recipharm said.   

A company spokesman also told us: "Except from the projects for China and Korea, Recipharm is working on a Group wide project to be able to meet the EU rules.​" 

Stephane Guisado, General Manager at Recipharm in Fontaine added: “Once again, our serialisation platform solution has proved the extent of its adaptability and resourcefulness for differing geographic and multi-country regulatory requirements. Indeed, in this case, it ensured that our customer complied in full with the relevant serialisation regulations set down by Korea​.”

Related news

Show more

Related products

show more

Next generation ePRO from SQN Health

Next generation ePRO from SQN Health

In an era of rapid technology growth, healthcare requires low cost solutions for real-time data collection. We have come a long way from paper to EDC and...


Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.


Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

How will Brexit affect the Pharmaceutical Industry?

How will Brexit affect the Pharmaceutical Industry?

Source BioScience Ltd | 08-Mar-2018 | Technical / White Paper

Have you prepared your strategy for the outcome of Brexit to ensure that you can continue to supply the UK market?
Source BioScience is a CRO with...

Related suppliers

Follow us


View more